Pharmacy & Technologies
Filter
230
Featured
Language
Document type
No document type
87
Guidelines
66
Manuals
35
Studies & Reports
16
Training Material
12
Fact sheets
5
Resource Platforms
4
Online Courses
2
Strategic & Response Plan
2
Videos
1
Countries / Regions
Latin America and the Carribbean
12
Africa
10
Global
9
Mozambique
6
Brazil
6
Angola
6
Sierra Leone
5
Liberia
5
Nigeria
4
Ghana
3
East and Southern Africa
3
Kenya
2
West and Central Africa
2
Ethiopia
2
India
2
Nepal
1
China
1
Syria
1
Malawi
1
Asia
1
Tanzania
1
Germany
1
Middle East and North Africa
1
Western Pacific Region
1
Bangladesh
1
Sudan
1
Mali
1
South Sudan
1
Somalia
1
Authors & Publishers
World Health Organization WHO
76
World Health Organization
25
WHO
10
Pan American Health Organisation PAHO
9
Africa CDC Centres for Disease Control and Prevention
7
African Union
7
World Health Organisation (WHO)
7
Organisation Mondiale de la Santé OMS
6
Organización Mundial de la Salud OMS
6
UNITAID
6
Centers of Disease Control CDC
5
Organisation Mondiale de la Santé (OMS)
5
World Health Organization (WHO)
5
Centers for Disease Control and Prevention (CDC)
3
Pan American Health Organization (PAHO)
3
Regional Office for Africa
3
Access to Medicine Foundation
2
Africa Center for Disease Control and Prevention
2
American Society of Hospital Pharmacists (ASHP)
2
ASHP
2
Centers for Disease Control and Prevention CDC
2
Cheesbrough, M.
2
International Union Against Tuberculosis and Lung Disease
2
MEDBOX
2
Médecins Sans Frontières
2
OPS
2
Organisation Mondiale de la Santé OMS
2
Organización Panamericana de la Salud
2
Pharm-Ed
2
USAID
2
A.Hill, T. Swan and K.Timmermans
1
Apotheker helfen
1
Apotheker helfen e.V.
1
Bernard M. Branson, S. Michele Owen, Laura G. Wesolowski et
1
Bundesinstitut für Arzneimittel und Medizinprodukte
1
C. Maari, M. guéguen, V. Grouzard
1
Cambridge University Press
1
CDC
1
Center for Disease Control
1
Centers for Disease control and Prevention
1
Cheesbrough, Monica
1
Clinical and Laboratory Standards Institute (CLSI)
1
Coherent Market Insights
1
College of American Pathologists
1
Corrado Barbui, Tarun Dua, Kavitha Kolappa et al.
1
Digital Journal
1
E. Heseltine
1
EMERGE
1
FIND
1
Foundation for Innovative and New Diagnostics
1
Francis Aboagye-Nyame, Heather Alexander, Zelalem Gizachew Belachew et al.
1
G. Walker
1
GLI
1
Global Pharma Health Fund E.V.
1
Hans L. Rieder, Armand Van Deun, Kai Man Kam, Sang Jae Kim, T. Martin Chonde, Arnaud Trébucq, Richard Urbanczik
1
Hesperian
1
Holm, thure
1
Hôpitaux universitaires de Genève
1
Indian Council of Medical Research India
1
IntechOpen
1
Jeff Conant and Pam Fadem
1
JSI Research & Training Institute, Inc., and Management Sciences for Health
1
Juan Samuel Sulca Herencia
1
Lloyd, Peter J.
1
M.M. El-Nageh
1
Management Science for Health MSH
1
Management Sciences for Health
1
Margie Barrett Joelle Cona Paul Hyde, et al.
1
Medicins Sans Frontieres
1
Ministerio da Saude, Brasilia
1
MSF Access Campaign
1
Novartis
1
Open WHO
1
Organisation de la Santé Mondiale
1
Organisation Mondiale de la Santé
1
Organizaición Mundial de la Salud
1
Ostenson, Harald
1
P. Palmer
1
PAHO
1
Pan American Health Organization
1
Pan American Health Organization PAHO
1
Peter Howitt, Ara Darzi, Guang-Zhong Yang, et al.
1
PLOS Neglected Tropical Diseases
1
Portaels, F-
1
Portaels, F.
1
Reports and Data
1
Richard Carr, Yves Chartier, Windy Gancayco Prohom et al.
1
Richard Lumb, Armand Van Deun, Ivan Bastian, Mark Fitz-Gerald
1
S. Groth, G. Forte et al.
1
Selon l’Organisation Mondiale de la Santé
1
SIGN
1
Singh-Phulgenda, S., Dahal, P., Ngu, R. et al.
1
Stop TB Parntership
1
Stop TB Partnership
1
The Global Health Network
1
The Imperial College
1
The Lancet Commission
1
THT Books
1
UNITAID Secretariat, World Health Organization
1
United States Pharmacopeial Convention
1
University of Delaware
1
University of Oxford
1
Uppsala Monitoring Centre
1
USAID Deliver Project
1
USAID, TB Care, SA Pathology
1
Velazquez Berumen, A.
1
WHO Tecnical Advisory Group and FIND
1
WHO, Pan American Health Organization
1
Word Health Organization
1
World Health Organization ( WHO), Regional Office for South-East-Asia
1
World Health Organization and Calouste Gulbenkian Foundation
1
World Health Organization et al.
1
World Health Organization WHO and World Intellectual Property Organization
1
World Health Organization WHO, Regional Office of Africa
1
World Health Organization WHO, Western Pacific Region
1
World Health Organization, ICRC, MSF, et al.
1
World Health Organization, Regional Office for Africa
1
World Health Organization, Regional Office for Eastern Mediterranean
1
World Health Organization, Regional Office for the Americas
1
World Health Organization, Regional Office South-East Asia
1
World Health Organization, United Nations Children's Fund, United Nations Development Programme, United Nations Populations Fund, World Bank
1
WTO, WHO, WIPO
1
Publication Years
Toolboxes
Pharmacy
40
Rapid Response
29
COVID-19
21
TB
18
Ebola
14
Natural Hazards
9
NTDs
7
HIV
5
Caregiver
5
Planetary Health
4
Cholera
3
Conflict
2
Zika
2
AMR
2
Refugee
1
Polio
1
Global Health Education
1
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control and accountability of biological materials and information related to these materials and dualuse research,... more
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control and accountability of biological materials and information related to these materials and dualuse research,... more
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control and accountability of biological materials and information related to these materials and dualuse research,... more
In 2009, WHO’s Second International Conference on Buruli Ulcer Control and Research resolved to strengthen the capacity of national laboratories to confirm cases of the disease, but advised that “efforts are still needed to develop simple diagnostic tools usable in the field as well as disabilit... more
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta... more
15 May 2022
Resource platform. The Global Atlas of medical devices (GAMD) provides global, regional and country data on availability of: national policy on health technology regulation of medical devices health technology assessment national unit health technology management use of med... more
he Framework sets the requirements for facilities handling High Consequence Agents and Toxins (HCATs) and guides the implementation of laboratory biosafety and biosecurity practices associated with the design, commissioning, routine operation safe and secure biocontainment laboratories.
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u... more
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a... more
The WHO BioHub Biosafety & Biosecurity: criteria and operational modalities sets out the requirements to which laboratories wishing to receive biological materials as part of this international exchange system should abide, to ensure safe and secure operations. These provisions are in accordance wit... more
To meet the need for laboratory diagnosis to be integrated in community care, the new 2022 Update describes point-of-care tests that can be performed both in district laboratories and peripheral healthcare facilities by non-specialist staff. Also included are recently developed self-tests.
GDF is the largest global provider of quality-assured tuberculosis (TB) medicines, diagnostics, and laboratory supplies to the public sector. Since 2001, GDF has facilitated access to high-quality TB care in over 130 countries, providing treatments to over 30 million people with TB and procuring ... more
The World Health Organization’s (WHO) global report for the year 2019 indicates that sub-Saharan Africa (SSA) has a very high maternal mortality rate (MMR) with a 2017 point estimate of 542 (UI 498 to 649) maternal deaths per 100 000 live births, accounting for approximately 66% of estimated globa... more
Decontamination of medical devices plays an important role in the prevention of health care-associated infections. It includes cleaning, disinfection and/or sterilization. The processes involved in decontamination are complex, require specific infrastructure and equipment, and involve several sequen... more
High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulati... more
This publication provides information for identifying, classifying, marking, labelling, packaging, documenting and refrigerating infectious substances for transportation and ensuring their safe delivery. The document provides practical guidance to facilitate compliance with applicable international... more
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included. The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot... more
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident... more
8 January 2021 Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int... more